IPO Listed
Alebund Pharmaceuticals (Jiangsu) IPO
HK$1.3bn raised
HKEX: 9637 · HK$22.60 cash per share
Advisers
Alebund Pharmaceuticals (Jiangsu)
Issuer
- Legal adviser
- Davis Polk

Team: Xuelin Wang, Jason Xu, Wendy Kan
Lead managers
- Bookrunner
- BofA Securities
(as Merrill Lynch (Asia Pacific))CITIC CLSA
(as CLSA) - Legal adviser
Other advisers
- Joint sponsors
- BofA Securities
(as Merrill Lynch (Asia Pacific))
- Issuer
- Alebund Pharmaceuticals (Jiangsu)
- Issuer based in
- China
- Listed
- 29 Jun 2026
- Sector
- Biotech
- Tags
- Biotech, Pharma
Similar deals
- Latigo Biotherapeutics IPO Aug 2026 · US$346m · Biotech
- Inovio Pharmaceuticals equity raising Jul 2026 · Biotech
- BridgeBio Pharma placement Jul 2026 · US$1bn · Biotech
- Mentari Therapeutics placement May 2026 · US$290m · Biotech
- Optimi Health Corp. equity raising May 2026 · US$15m · Biotech
Sources
- Jul 2026 Kirkland Assists Alebund on its Hong Kong IPO kirkland.com
- 1 Jul 2026 Alebund Pharmaceuticals HK$1.28 billion IPO davispolk.com

